FDA Announces Public Meeting of Dermatologic and Ophthalmic Drugs Advisory Committee

Summary

The FDA is hosting a public meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee to provide advice on FDA's regulatory issues, with public attendance invited.